Why is Chemo Pharma Lab falling/rising?

As of 08-Oct, Chemo Pharma Laboratories Ltd is experiencing a price increase, with its current price at Rs 134.70, reflecting a rise of Rs 13.0 or 10.68%. The stock has shown a strong performance today, outperforming its sector by 10.9% and reversing a trend after two consecutive days of decline. It reached an intraday high of Rs 138.8, indicating significant volatility with an intraday fluctuation of 6.44%. Over the past week, the stock has gained 12.25%, and it has demonstrated impressive returns over longer periods, including a 126.08% increase over the past year and a remarkable 517.89% rise over the last five years. However, there is a notable decline in investor participation, with delivery volume dropping by 85.1% compared to the five-day average, which may impact future price stability.
Broader Market Context: In comparison to the benchmark Sensex, which has increased by only 0.98% over the past week, Chemo Pharma Laboratories Ltd's performance is significantly stronger, highlighting its relative strength in the market. The stock's year-to-date return of 22.63% also surpasses the Sensex's 4.65%, indicating that it is not only performing well in isolation but is also gaining traction against broader market trends. This strong performance amidst a generally stable market environment suggests that investor sentiment towards Chemo Pharma is positive, despite the recent drop in delivery volume, which could indicate a temporary shift in trading activity rather than a fundamental weakness in the stock itself.